Related references
Note: Only part of the references are listed.Effect of Artesunate-Amodiaquine on Mortality Related to Ebola Virus Disease
Etienne Gignoux et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Ebola virus (EBOV) infection: Therapeutic strategies
Erik De Clercq
BIOCHEMICAL PHARMACOLOGY (2015)
Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV/AIDS
Andrea Savarino et al.
RETROVIROLOGY (2015)
Chloroquine use improves dengue-related symptoms
Marcos Carvalho Borges et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2013)
A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents
Peter B. Madrid et al.
PLOS ONE (2013)
Effects of Hydroxychloroquine on Immune Activation and Disease Progression Among HIV-Infected Patients Not Receiving Antiretroviral Therapy A Randomized Controlled Trial
Nicholas I. Paton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Cathepsin B & L Are Not Required for Ebola Virus Replication
Andrea Marzi et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders
Stefania Piconi et al.
BLOOD (2011)
Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial
Nicholas I. Paton et al.
LANCET INFECTIOUS DISEASES (2011)
Blood concentrations are better predictors of chioroquine poisoning severity than plasma concentrations: a prospective study with modeling of the concentration/effect relationships
Bruno Megarbane et al.
CLINICAL TOXICOLOGY (2010)
Reduction of Immune Activation with Chloroquine Therapy during Chronic HIV Infection
Shannon M. Murray et al.
JOURNAL OF VIROLOGY (2010)
A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults
Vianney Tricou et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
On the use of chloroquine for chikungunya
Andrea Savarino et al.
LANCET INFECTIOUS DISEASES (2007)
Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses
Livia Di Trani et al.
VIROLOGY JOURNAL (2007)
In vitro inhibition of human influenza A virus replication by chloroquine
Eng Eong Ooi et al.
VIROLOGY JOURNAL (2006)
New insights into the antiviral effects of chloroquine
A Savarino et al.
LANCET INFECTIOUS DISEASES (2006)
Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection
K Chandran et al.
SCIENCE (2005)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
Interferon-γ:: an overview of signals, mechanisms and functions
K Schroder et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
E Keyaerts et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques - Evidence that dendritic cells are early and sustained targets of infection
TW Geisbert et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: Overexpression of tissue factor in primate monocytes/macrophages is a key event
TW Geisbert et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis
T Munster et al.
ARTHRITIS AND RHEUMATISM (2002)
Neopterin as a marker for immune system activation
C Murr et al.
CURRENT DRUG METABOLISM (2002)
Inflammatory responses in Ebola virus-infected patients
S Baize et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity
A Savarino et al.
AIDS (2001)
Human asymptomatic Ebola infection and strong inflammatory response
EM Leroy et al.
LANCET (2000)
Share Paper
